Pharma, chemical stocks lead under lockdown, Aurobindo is top performer

Within BSE-500, 79% stocks gave positive returns in two months of lockdown

Markets have seen strong signs of recovery during the lockdown, with pharma and chemical sector stocks delivering 14-100 per cent gains during this period.

An analysis of BSE500 universe shows 79 per cent (or 395 stocks) delivered positive returns, while 21 per cent (or 105 stocks) gave negative returns during the lockdown, starting March 25. 

“After the sell-off in March, the indices started reflecting concerns. After lockdown, there was expectation that the situation could be brought under control,” said Deepak Jasani, head-retail research, HDFC Securities.

Among pharma stocks, Aurobindo Pharma has been a top performer, with over 2x returns (142 per cent gains).